Abraxane, an albumin-bound PTX, was modified with LyP-1 or CREKA via their cysteine sulfhydryl group using a sulfo-SMCC cross-linker to evaluate the inhibition of tumor growth in tumor-bearing mice with MDA-MB-435 cells. The gene discussed is PTPN22; the disease is neoplasm.